Biotech
VANCOUVER, BRITISH COLUMBIA: Lee Buckler, former VP Business & Corporate Development, appointed CEO President & Director; David Hall retires as CEO and named Board Chairman ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/15/15 -- Med BioGene Inc. (the "Company") (TSX VENTURE: MBI) is very pleased to be able to confirm that our licensee, Helomics™ has adv ...
GENEVA, SWITZERLAND: The Abstract Presented Data on NI-0501, an Experimental Drug for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH) ...
MONCTON, NEW BRUNSWICK: MONCTON, NEW BRUNSWICK -- (Marketwired) -- 12/15/15 -- Soricimed Biopharma Inc. (""), a clinical-stage pharmaceutical company discovering and developing peptide-based cancer therapeutics, t ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/15/15 -- M Pharmaceutical, Inc. (CSE: MQ)(OTCQB: MPHMF)(FRANKFURT: T3F2), (the "Company" or "M Pharma"), announced that Martin ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 12/14/15 -- MedMira Inc. (MedMira) (TSX VENTURE: MIR), reported today on its financial results for the three month period ending October 31, 2015. The Company ...
COLUMBIA, MD and TORONTO, ON: COLUMBIA, MD and TORONTO, ON -- (Marketwired) -- 12/14/15 -- Medifocus Inc. (TSX VENTURE: MFS) (OTCQX: MDFZF) ("Medifocus" or the "Company") announces that it has completed the fi ...
MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 12/14/15 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that tre ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 12/14/15 -- (NASDAQ: CBLI)and today announced the publication of a study in Oncotarget demonstrating the ability of entolimod to suppress liver metastases in a preclin ...
CAMBRIDGE, MA: Promotes Ben Munoz, Ph.D. to Senior Vice President, Drug Discovery and Po-Shun Lee, M.D. to Executive Vice President and Chief Medical Officer ...
SYDNEY, AUSTRALIA: New Material Transfer Agreement (MTA) Concluded With Yamaguchi University and NEC Corporation Parties Have Combined a Cancer Vaccine With Prima's IMP321 Antigen Presenting Cell (APC) Activator Pr ...
DUBLIN, IRELAND: First-in-Human Study for Potentially Best-in-Class Treatment for Range of Inflammatory Intestinal Diseases ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 12/09/15 -- (NASDAQ: TTNP) and partner Braeburn Pharmaceuticals today announced that the U.S. Food and Drug Administration has scheduled a meeting of the ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/09/15 -- bioMmune Technologies Inc. ("bioMmune" or the "Company") (TSX VENTURE: IMU), a company focused on harnessing the body& ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 12/08/15 -- BioNeutra Global Corporation ("BioNeutra" or the "Company") is pleased to announce that the common shares of the Company will be ...
DUBLIN, IRELAND: First Clinical Study for Compound From Company's Potential Best-in-Class NEP Inhibitor Development Program; Compound Designed for Broad Use in Major Cardiovascular and Renal Diseases ...
WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwired) -- 12/08/15 -- Miraculins Inc. (TSX VENTURE: MOM) (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing dia ...
ATLANTA, GEORGIA: New Whole Blood Applications Powered by Medmira Rapid Vertical Flow Technology Revealed at Booth 109 ...
